sign uplog in
Want to go ad-free? Find out how, here.

NZ life insurance market consolidates as ANZ agrees to sell OnePath Life to Cigna for $700 million; Sale to see Cigna become NZ's third largest life insurer

NZ life insurance market consolidates as ANZ agrees to sell OnePath Life to Cigna for $700 million; Sale to see Cigna become NZ's third largest life insurer

ANZ New Zealand has agreed to sell its life insurance business, OnePath Life NZ, to Cigna Corporation for NZ$700 million.

The sale will see Cigna become the third largest life insurance company in New Zealand.

Under the agreement Cigna will underwrite insurance for ANZ for 20 years.

“ANZ will continue to provide life insurance to our customers but these insurance policies will now be manufactured and managed by a world-class insurance provider in Cigna,” ANZ New Zealand CEO, David Hisco, says.

“This is consistent with how we provide motor vehicle, home, commercial and travel insurance using a range of specialist insurance partners.”

ANZ says OnePath Life policyholders will keep being covered under the terms of their policies and "it is intended" all staff involved will be offered similar roles with Cigna or ANZ.

Hisco says the deal aligns with ANZ’s strategy to simplify its business.

ANZ in December announced it would sell its Australian life insurance business to Zurich Financial Services Australia for A$2.85 billion.

The bank says it’s selling OnePath Life for more than its book value, with the sale strengthening its capital position a little.

“The transaction represents a slight premium to embedded value and is expected to generate a gain on sale of around NZ$50 million, increasing ANZ Group’s Level 1 and Level 2 CET1 ratios by ~5 basis points and ~15 basis points respectively,” it says.

Cigna New Zealand CEO, Gail Costa, says the “acquisition and strategic alliance diversifies Cigna’s distribution capabilities”.

“This acquisition will enable us to provide broader solutions and be more agile and responsive to a larger customer base.”

Having entered the New Zealand market almost 100 years ago, Cigna New Zealand has more than 350,000 New Zealand customers. It has also been one of ANZ’s insurance partners for more than 20 years.

Cigna Corporation is one of the world's largest publicly-owned insurance and financial services companies. It has 95 million customers and more than 40,000 employees worldwide.

The OnePath Life sale remains subject to regulatory approval and is expected to be complete in the 2019 financial year.

ANZ New Zealand’s Investment Management business is not part of the sale.

The ANZ/Cigna deal follows ASB’s parent, the Commonwealth Bank of Australia, in September announcing it had agreed to sell its Australian and New Zealand life insurance businesses -CommInsure Life and Sovereign - to AIA for A$3.8 billion.

With the sale expected to be completed by the end of year, Sovereign remains New Zealand’s largest life insurer.

Like OnePath Life, Sovereign and CommInsure are being sold for more than their book values.

We welcome your comments below. If you are not already registered, please register to comment.

Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.


Looks like continued consolidation in the life insurance market - we're heading towards an oligopoly like the fire & general market

Was thinking the same, will this be rubber stamped or given serious consideration? There are fewer and fewer independently operating within this space, if ANZ Bank exit as well...

A 20 year deal? God forbid any future CEO wants to take their approach to insurance in a different direction....

Why is ANZ wanting to sell off all its non-core businesses that were bought with the view to expanding their bank/assurance/ asset finance offering ?

First it was UDC and this .

What the real motive ?

Life insurance is capital intensive with low growth. Redeploy the capital to more profitable & higher growth ventures.

They will still maintain the profitable and morally questionable ability to cross-sell insurance to their bank customers